Senior insider sale
Chief Commercial Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$537.3K
14.53K shares
What this filing means
HEERMA PETER plans to sell 14.53K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $537.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001193125-26-155537
Officer· Chief Commercial Officer
Since Oct 2019
14.53K
Shares to sell
$537.3K
Approx. market value
7.21K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Performance Restricted Stock Unit Vesting
Compensation
4/13/2026
7.21KTotal acquired7.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2026 | Performance Restricted Stock Unit Vesting Compensation | 7.21K | — |
| Total | 7.21K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.31K
Market value
$234.8K
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.21K
Market value
$302.5K
4/14/2026
Total
Units
14.53K
Value
$537.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 7.31K | $234.8K | — | Completed |
| Planned — Approximate Date | ||||
4/14/2026 | 7.21K | $302.5K | NASDAQ | Planned |
| Total | 14.53K | $537.3K | ||